Clinical Predictors of Mortality in Patients with Moderate to Severe Mitral Regurgitation

Published:October 11, 2021DOI:



      Mitral regurgitation is the most common form of valvular heart disease worldwide, however, there is an incomplete understanding of predictors of mortality in this population. This study sought to identify risk factors of mortality in a real-world population with mitral regurgitation.


      All patients with moderate or severe mitral regurgitation were identified at a single center from January 1, 2016 to August 31, 2017. Multivariate regression was performed to evaluate variables independently associated with all-cause mortality.


      A total of 490 patients with moderate (76.3%) or severe (23.7%) mitral regurgitation due to primary (20.8%) or secondary (79.2%) etiology were identified. The mean age was 66.7 years; 50% were male. At a median follow-up of 3.1 years, the incidence of all-cause mortality was 30.1%, heart failure hospitalization 23.1%, and mitral valve intervention 11.6%. Of 117 variables, multivariate analysis demonstrated 5 that were independently predictive of mortality: baseline creatinine (hazard ratio [HR] 1.2; 95% CI, 1.0-1.3; P = .02), right atrial pressure by echocardiogram (HR 1.3; 95% CI, 1.07-1.55; P = .008), hemoglobin (HR 0.65; 95% CI, 0.52-0.83; P = .001), hospitalization for heart failure (HR 1.6; 95% CI, 1.1-2.4; P = .015), and mitral valve intervention (HR 0.40; 95% CI, 0.16-0.83; P = .049).


      In this retrospective, pragmatic analysis of patients with moderate or severe mitral regurgitation, admission for heart failure exacerbation, elevated right atrial pressure, renal dysfunction, anemia, and lack of mitral valve intervention were independently associated with increased risk of all-cause mortality. Whether these risk factors may better identify select patients who may benefit from more intensive monitoring or earlier intervention should be considered in future studies.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nkomo VT
        • Gardin JM
        • Skelton TN
        • Gottdiener JS
        • Scott CG
        • Enriquez-Sarano M
        Burden of valvular heart diseases: a population-based study.
        Lancet. 2006; 368: 1005-1011
        • El Sabbagh A
        • Reddy YNV
        • Nishimura RA
        Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions.
        JACC Cardiovasc Imaging. 2018; 11: 628-643
        • Andell P
        • Li X
        • Martinsson A
        • et al.
        Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.
        Heart. 2017; 103: 1696-1703
        • Moore M
        • Chen J
        • Mallow PJ
        • Rizzo JA
        The direct health-care burden of valvular heart disease: evidence from US national survey data.
        Clinicoecon Outcomes Res. 2016; 8: 613-627
        • Grigioni F
        • Enriquez-Sarano M
        • Zehr KJ
        • Bailey KR
        • Tajik AJ
        Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment.
        Circulation. 2001; 103: 1759-1764
        • Stone GW
        • Lindenfeld J
        • Abraham WT
        • et al.
        Transcatheter mitral-valve repair in patients with heart failure.
        N Engl J Med. 2018; 379: 2307-2318
        • Shah M
        • Jorde UP
        Percutaneous mitral valve interventions: current indications and future perspectives.
        Front Cardiovasc Med. 2019; 6: 88
        • Zoghbi WA
        • Adams D
        • Bonow RO
        • et al.
        Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.
        J Am Soc Echocardiogr. 2017; 30: 303-371
        • Nishimura RA
        • Otto CM
        • Bonow RO
        • et al.
        2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 63: 2438-2488
        • Watanabe S
        A widely applicable Bayesian information criterion.
        J Mach Learn Res. 2013; 14: 867-897
        • Ling LH
        • Enriquez-Sarano M
        • Seward JB
        • et al.
        Clinical outcome of mitral regurgitation due to flail leaflet.
        N Engl J Med. 1996; 335: 1417-1423
        • Crowe F
        • Zemedikun DT
        • Okoth K
        • et al.
        Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK.
        Heart. 2020; 106: 810-816
        • Azzalini L
        • Chabot-Blanchet M
        • Southern DA
        • et al.
        A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition.
        CMAJ. 2019; 191: E299-E307
        • Rashid M
        • Kwok CS
        • Gale CP
        • et al.
        Impact of co-morbid burden on mortality in patients with coronary heart disease, heart failure, and cerebrovascular accident: a systematic review and meta-analysis.
        Eur Heart J Qual Care Clin Outcomes. 2017; 3: 20-36
        • Sarnak MJ
        • Tighiouart H
        • Manjunath G
        • et al.
        Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study.
        J Am Coll Cardiol. 2002; 40: 27-33
        • Michalak SS
        • Rupa-Matysek J
        • Gil L
        Comorbidities, repeated hospitalizations, and age ≥ 80 years as indicators of anemia development in the older population.
        Ann Hematol. 2018; 97: 1337-1347
        • Tigen K
        • Karaahmet T
        • Kirma C
        • et al.
        The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy.
        Cardiol J. 2010; 17: 274-280
        • Meemook K
        • Nakajima Y
        • Nakamura M
        • Hussaini A
        • Kar S
        Anaemia is a predictor of mortality in patients with mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair.
        Eur Heart J. 2017; 38: p1386
        • Samad Z
        • Sivak JA
        • Phelan M
        • Schulte PJ
        • Patel U
        • Velazquez EJ
        Prevalence and outcomes of left-sided valvular heart disease associated with chronic kidney disease.
        J Am Heart Assoc. 2017; 6e006044
        • Solomon SD
        • Dobson J
        • Pocock S
        • et al.
        Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
        Circulation. 2007; 116: 1482-1487
        • Pocock SJ
        • Wang D
        • Pfeffer MA
        • et al.
        Predictors of mortality and morbidity in patients with chronic heart failure.
        Eur Heart J. 2006; 27: 65-75
        • Gillinov AM
        • Mihaljevic T
        • Blackstone EH
        • et al.
        Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop?.
        Ann Thorac Surg. 2010; 90: 481-488
        • Tribouilloy C
        • Grigioni F
        • Avierinos JF
        • et al.
        Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study.
        J Am Coll Cardiol. 2009; 54: 1961-1968
        • Dziadzko V
        • Clavel MA
        • Dziadzko M
        • et al.
        Outcome and undertreatment of mitral regurgitation: a community cohort study.
        Lancet. 2018; 391: 960-969